Drugs & Aging

, Volume 15, Issue 5, pp 335–340 | Cite as

Drugs Used in Physician-Assisted Death

  • Dick L. WillemsEmail author
  • Johanna H. Groenewoud
  • Gerrit van der Wal
Leading Article


Epidemiological studies, case reports, and recommendations concerning the drugs used in physician-assisted death are reviewed in this paper. Using a MEDLINE and Cancerlit search, we found a total of 20 relevant publications. Recent research, mainly from the Netherlands, has shown that high doses of barbiturates are usually effective for physician-assisted suicide, while a combination of a barbiturate and a derivative of curare are effective for euthanasia. Opioids are less reliable drugs for physician-assisted death because of the unpredictable duration of the dying process even after high doses. The same applies to benzodiazepines. The most frequent undesired effect is an unexpectedly long dying process due to impaired uptake of the drugs. Although the evidence base is incomplete, the Dutch recommendations issued in 1994 and renewed in 1998 do not seem inappropriate.


Adis International Limited Barbiturate Potassium Chloride Assisted Suicide Neuromuscular Relaxant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Quill TE. Death and dignity. A case of individualized decision making. N Engl J Med 1991; 324(10): 691–4PubMedCrossRefGoogle Scholar
  2. 2.
    Anonymous. A piece of my mind: it’s over, Debbie. JAMA 1988; 259(2): 272Google Scholar
  3. 3.
    van der Maas PJ, Van der Wal G, Haverkate I, et al. Euthanasia, physician-assisted suicide, and other medical practices involving the end of life in the Netherlands, 1990–1995. N Engl J Med 1996; 335(22): 1699–705PubMedCrossRefGoogle Scholar
  4. 4.
    van der Wal G, Van der Maas PJ, Bosma JM, et al. Evaluation of the notification procedure for physician-assisted death in the Netherlands. N Engl J Med 1996; 335(22): 1706–11PubMedCrossRefGoogle Scholar
  5. 5.
    van der Maas PJ, Van Delden JJ, Pijnenborg L, et al. Euthanasia and other medical decisions concerning the end of life. Lancet 1991; 338(8768): 669–74CrossRefGoogle Scholar
  6. 6.
    Emanuel EJ, Fairclough DL, Daniels ER, et al. Euthanasia and physician-assisted suicide: attitudes and experiences of oncology patients, oncologists, and the public. Lancet 1996; 347(9018): 1805–10PubMedCrossRefGoogle Scholar
  7. 7.
    Drickamer MA, Lee MA, Ganzini L. Practical issues in physician-assisted suicide. Ann Intern Med 1997; 126(2): 146–51PubMedGoogle Scholar
  8. 8.
    Lee MA, Nelson HD, Tilden VP, et al. Legalizing assisted suicide: views of physicians in Oregon. N Engl J Med 1996; 334(5): 310–5PubMedCrossRefGoogle Scholar
  9. 9.
    van der Wal G, Van Eijk JT, Leenen HJ, et al. The use of drugs for euthanasia and assisted suicide in family practice. (in Dutch). Neth Tijdschr Geneeskd 1992; 136(27): 1299–305Google Scholar
  10. 10.
    Laane HM. Euthanasia, assisted suicide and AIDS. AIDS Care 1995; 7Suppl. 2: S163–7CrossRefGoogle Scholar
  11. 11.
    Muller MT, Hertogh C, Van der Wal G, et al. Medico-technical aspects of euthanasia and assisted suicide in nursing home medicine [in Dutch]. Vox Hospitii 1992; 163–7Google Scholar
  12. 12.
    Chin A, Hedberg K, Higginson G, et al. Legalized physician-assisted suicide in Oregon: the first year’s experience. N Engl J Med 1999; 340(7): 577–81PubMedCrossRefGoogle Scholar
  13. 13.
    Onwuteaka-Philipsen BD, Muller MT, Van der Wal G. Euthanatics: implementation of a protocol to standardise euthanatics among pharmacists and GPs. Patient Educ Couns 1997; 31(2): 131–7PubMedCrossRefGoogle Scholar
  14. 14.
    Statistics Netherlands. The end of life in medical practice (1995, 1990) [in Dutch]. Den Haag: Centraal Bureau voor de Statistiek, 1996Google Scholar
  15. 15.
    van der Wal G, van der Maas PJ. Euthanasia and other medical decisions concerning the end of life: practice and notification procedure [in Dutch]. Den Haag: SDU, 1996Google Scholar
  16. 16.
    Preston T, Mero R. Observations concerning terminally ill patients who choose suicide. J Pharm Care Pain Sympt Control 1996; 4: 183–92CrossRefGoogle Scholar
  17. 17.
    Stapczynski JS, Haskell RJ. Duration of hypoglycemia and need for intravenous glucose following intentional overdoses of insulin. Ann Emerg Med 1984; 13(7): 505–11PubMedCrossRefGoogle Scholar
  18. 18.
    Cooper A. Attempted suicide using insulin by a non diabetic. Can J Psych 1994; 29(3): 103–7Google Scholar
  19. 19.
    Chao T, Lo D, Chui P, et al. The first fatal propofol poisoning in Singapore. Forensic Sci Int 1994; 66(1): 1–7PubMedCrossRefGoogle Scholar
  20. 20.
    Arem R, Zoghbi W. Insulin overdose in eight patients: insulin pharmacokinetics and review of the literature. Medicine 1985; 64(5): 323–32PubMedCrossRefGoogle Scholar
  21. 21.
    Kaminer Y, Robbins DR. Attempted suicide by insulin overdose in insulin-dependent diabetic adolescents. Pediatrics 1988; 81(4): 526–8PubMedGoogle Scholar
  22. 22.
    Martin FI, Hansen N, Warne GL. Attempted suicide by insulin overdose in insulin-requiring diabetics. Med J Aust 1977; 1(3): 58–60PubMedGoogle Scholar
  23. 23.
    Wetli CV, Davis JH. Fatal hyperkalemia from accidental overdose of potassium chloride. JAMA 1978; 240(13): 1339PubMedCrossRefGoogle Scholar
  24. 24.
    Jamison S. When drugs fail: assisted deaths and not-so-lethal drugs. In: Battin M, Lipman A, editors. Drug use in assisted suicide and euthanasia. New York: Haworth Press, 1996: 223–45Google Scholar
  25. 25.
    Admiraal PV. Administration of euthanasia-inducing agents [in Dutch]. Neth Tijdschr Geneeskd 1995; 139(6): 265–8Google Scholar
  26. 26.
    Humphrey D. Final exit: the practicalities of self-deliverance and assisted suicide for the dying. Eugene (OR): Hemlock Society, 1991Google Scholar
  27. 27.
    Smith C, Docker C. Departing drugs. An international guidebook to self-deliverance. Edinburgh: 1993Google Scholar
  28. 28.
    Inturissi C, Hanks G. Opioid analgesic therapy. In: Doyle D, Hanks G, MacDonald N, editors. Oxford textbook of palliative medicine. 2nd ed. Oxford: Oxford University Press, 1998: 166–82Google Scholar
  29. 29.
    Sumner DJ, Kalk J, Whiting B. Metabolism of barbiturate after overdosage. BMJ 1975; 1(5953): 335PubMedCrossRefGoogle Scholar
  30. 30.
    Quill TE, Lo B, Brock DW. Palliative options of last resort: a comparison of voluntarily stopping eating and drinking, terminal sedation, physician-assisted suicide, and voluntary active euthanasia. JAMA 1997; 278(23): 2099–104PubMedCrossRefGoogle Scholar
  31. 31.
    Rousseau P. Terminal sedation in the care of dying patients. Arch Intern Med 1996; 156(16): 1785–6PubMedCrossRefGoogle Scholar
  32. 32.
    Onwuteaka-Philipsen BD, Muller MT, Van der Wal G, et al. Active voluntary euthanasia or physician-assisted suicide? J Am Geriatr Soc 1997; 45(10): 1208–13PubMedGoogle Scholar
  33. 33.
    Crouch B. Toxicological issues with drugs used to end life. In: Battin M, Lipman A, editors. Drug use in assisted suicide and euthanasia. New York: Haworth Press, 1996: 211–23Google Scholar
  34. 34.
    Park GR, Miller E. What changes drug metabolism in critically ill patients-III? Effect of pre-existing disease on the metabolism of midazolam. Anaesthesia 1996; 51(5): 431–4PubMedCrossRefGoogle Scholar
  35. 35.
    Jung D, Prasad PP. Influence of nutritional status on the pharmacokinetics and pharmacodynamics of pentobarbital. Drug Metab Dispos 1989; 17(4): 365–8PubMedGoogle Scholar
  36. 36.
    Stavchansky S, Tung IL. Effects of hypothermia on drug absorption. Pharm Res 1987; 4(3): 248–50PubMedCrossRefGoogle Scholar
  37. 37.
    Penfold N, Park G. Effects of organ failure and therapy on drug metabolism. Curr Opin Aneasth 1990; 3: 235–40CrossRefGoogle Scholar
  38. 38.
    Power BM, Hackett LP, Dusci LJ, et al. Antidepressant toxicity and the need for identification and concentration monitoring in overdose. Clin Pharmacokinet 1995; 29(3): 154–71PubMedCrossRefGoogle Scholar
  39. 39.
    Saxena K. Clinical features and management of poisoning due to potassium chloride. Med Toxicol Adverse Drug Exp 1989; 4(6): 429–43PubMedGoogle Scholar
  40. 40.
    Koninklijke Nederlandse Maatschappij ter Bevordering der Pharmacie (KNMP). Technical report concerning euthanatics [in Dutch]. Den Haag: KNMP, 1987Google Scholar
  41. 41.
    Wetenschappelijk Instituut Nederlandse Apothekers. Advices for the application of euthanatics [in Dutch]. Medisch Contact 1998; 53(43): 1366–8Google Scholar
  42. 42.
    Kimsma GK. Clinical ethics in assisting euthanasia: avoiding malpractice in drug application. J Med Phil 1992; 17(4): 439–43Google Scholar

Copyright information

© Adis International Limited 1999

Authors and Affiliations

  • Dick L. Willems
    • 1
    Email author
  • Johanna H. Groenewoud
    • 2
  • Gerrit van der Wal
    • 1
  1. 1.Institute for Research in Extramural Medicine and Department of Social MedicineVrije UniversiteitAmsterdamThe Netherlands
  2. 2.Department of Public HealthErasmus UniversityRotterdamThe Netherlands

Personalised recommendations